US4203802A
(en)
*
|
1971-05-14 |
1980-05-20 |
Syva Company |
Inhibitable enzyme amplification assay
|
US3875011A
(en)
*
|
1972-11-06 |
1975-04-01 |
Syva Co |
Enzyme immunoassays with glucose-6-phosphate dehydrogenase
|
US3904367A
(en)
*
|
1973-08-15 |
1975-09-09 |
Gen Electric |
Contrast enhancement for immunological film detection
|
US4039652A
(en)
*
|
1973-10-11 |
1977-08-02 |
Miles Laboratories, Inc. |
Column method of immunoassay employing an immobilized binding partner
|
US3951748A
(en)
*
|
1974-11-11 |
1976-04-20 |
Medical Products, Inc. |
Sensitized matrix for detection of disease
|
SE388694B
(en)
*
|
1975-01-27 |
1976-10-11 |
Kabi Ab |
WAY TO PROVIDE AN ANTIGEN EXV IN SAMPLES OF BODY WHEATS, USING POROST BERAR MATERIAL BONDED OR ADSORBING ANTIBODIES
|
NL7501215A
(en)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
METHOD FOR DETERMINING AND DETERMINING AN ANTIGEN OR ANTIBODY.
|
IN142734B
(en)
*
|
1975-04-28 |
1977-08-20 |
Miles Lab |
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4016043A
(en)
*
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
US4642285A
(en)
*
|
1975-09-29 |
1987-02-10 |
Diamedix Corporation |
Sandwich EIA for antigen
|
SE7610683L
(en)
*
|
1975-09-29 |
1977-06-10 |
Cordis Corp |
METHOD OF DETERMINING THE NERVARON OF AN ANTIGEN ASSOCIATE WITH HEPATITIS
|
US4474878A
(en)
*
|
1975-09-29 |
1984-10-02 |
Cordis Laboratories, Inc. |
Sandwich EIA for antigen associated with hepatitis
|
US4116776A
(en)
*
|
1976-04-19 |
1978-09-26 |
International Radioimmune Systems, Inc. |
Diagnostic blood test and kit for detecting human chorionic gonadotropin
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
GB1549069A
(en)
*
|
1976-12-10 |
1979-08-01 |
Erba Farmitalia |
Enzyme linked immunoassay
|
JPS5399319A
(en)
*
|
1977-02-09 |
1978-08-30 |
Hidematsu Hirai |
Novel qualitative and quantitative detecting method and detecting body for antgenic substance
|
IT1153999B
(en)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
COMPOSITION SUITABLE FOR DETERMINING TRIIODOTHYRONIN AND DIAGNOSTIC METHOD USING THE SAME
|
IL51668A
(en)
*
|
1977-03-16 |
1981-12-31 |
Israel State |
Analytical method for the quantitative determination of immunogens and antibodies and a kit therefor
|
CA1108516A
(en)
*
|
1977-11-21 |
1981-09-08 |
Stanley E. Charm |
Antibiotic detection method
|
US4275149A
(en)
*
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
NL7804144A
(en)
*
|
1978-04-18 |
1979-10-22 |
Akzo Nv |
DEVICE FOR CLORIMETRIC PROVISIONS.
|
NZ190452A
(en)
*
|
1978-05-19 |
1981-04-24 |
Becton Dickinson Co |
Solid phase assay receptor contacted with analyte and then with labeled analyte
|
JPS54170918U
(en)
*
|
1978-05-23 |
1979-12-03 |
|
|
US4273756A
(en)
*
|
1978-07-28 |
1981-06-16 |
Abbott Laboratories |
Immunoassay for class specific antibodies
|
US4292296A
(en)
*
|
1978-09-12 |
1981-09-29 |
Baxter Travenol Laboratories, Inc. |
Diagnostic method
|
US4240751A
(en)
*
|
1978-11-09 |
1980-12-23 |
Akzona Incorporated |
Method and apparatus for specific binding substances
|
US4318707A
(en)
*
|
1978-11-24 |
1982-03-09 |
Syva Company |
Macromolecular fluorescent quencher particle in specific receptor assays
|
US4374925A
(en)
*
|
1978-11-24 |
1983-02-22 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
JPS55116258A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
JPS55116259A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
US4269938A
(en)
*
|
1979-03-08 |
1981-05-26 |
Eastman Kodak Company |
Assay of peroxidatively active materials
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
GB2059421A
(en)
*
|
1979-10-03 |
1981-04-23 |
Self C H |
Assay method and reagents therefor
|
US4446231A
(en)
*
|
1979-10-03 |
1984-05-01 |
Self Colin H |
Immunoassay using an amplified cyclic detection system
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
JPS56143955A
(en)
*
|
1980-04-10 |
1981-11-10 |
Fujirebio Inc |
Method for diagnosis of initial infection of syphilis
|
AU543007B2
(en)
*
|
1980-04-15 |
1985-03-28 |
Technicon Instruments Corportion |
Agglutination immunoassay
|
DE3016575A1
(en)
*
|
1980-04-30 |
1981-11-05 |
Merck Patent Gmbh, 6100 Darmstadt |
METHOD FOR THE IMMUNOLOGICAL DETERMINATION OF ENZYMES, MEANS FOR CARRYING OUT THE METHOD AND ITS RELATIONSHIP
|
EP0111762B1
(en)
*
|
1980-06-20 |
1987-11-19 |
Unilever Plc |
Processes and apparatus for carrying out specific binding assays
|
US6406920B1
(en)
|
1980-06-20 |
2002-06-18 |
Inverness Medical Switzerland Gmbh |
Processes and apparatus for carrying out specific binding assays
|
NL185309C
(en)
|
1980-07-28 |
1990-03-01 |
Akzo Nv |
METHOD FOR DETERMINING ANTIGENS USING TWO OR MORE MONOCLONAL ANTIBODIES AND IMMUNE REAGENTS.
|
US4486530A
(en)
*
|
1980-08-04 |
1984-12-04 |
Hybritech Incorporated |
Immunometric assays using monoclonal antibodies
|
US4376110A
(en)
*
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
NZ199286A
(en)
*
|
1980-12-22 |
1986-05-09 |
Commw Serum Lab Commission |
A method of detecting antibodies or an antigenic or haptenic substance in a sample
|
US4517288A
(en)
*
|
1981-01-23 |
1985-05-14 |
American Hospital Supply Corp. |
Solid phase system for ligand assay
|
US4425438A
(en)
*
|
1981-03-13 |
1984-01-10 |
Bauman David S |
Assay method and device
|
GB2095258B
(en)
*
|
1981-03-19 |
1984-09-05 |
Janssen Pharmaceutica Nv |
A bright field light microscopic method of localizing tissue antigens
|
US4592995A
(en)
*
|
1981-03-30 |
1986-06-03 |
Dainippon Pharmaceutical Co., Ltd. |
Reagent for streptococcal anti-esterase assay
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
JPS57193643U
(en)
*
|
1981-06-03 |
1982-12-08 |
|
|
US4447528A
(en)
*
|
1981-08-10 |
1984-05-08 |
Corning Glass Works |
Detecting intrinsic factor blocking site antibody
|
EP0091911A4
(en)
*
|
1981-08-31 |
1984-04-06 |
Icl Scient |
Glucose oxidase immunohistochemical detection of antinuclear antibodies.
|
US4452886A
(en)
*
|
1981-09-21 |
1984-06-05 |
Henry Robert P |
Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems
|
US4446232A
(en)
*
|
1981-10-13 |
1984-05-01 |
Liotta Lance A |
Enzyme immunoassay with two-zoned device having bound antigens
|
US4753875A
(en)
*
|
1981-11-02 |
1988-06-28 |
Ryan James W |
Method for assaying proteases with tagged proteinaceous inhibitors
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4469787A
(en)
*
|
1982-05-14 |
1984-09-04 |
Mallinckrodt Inc. |
Immunoassay involving soluble complex of second antibody and labeled binding protein
|
US4503143A
(en)
*
|
1982-08-20 |
1985-03-05 |
Btc Diagnostics Limited Partnership |
Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
|
US4530900A
(en)
*
|
1982-09-13 |
1985-07-23 |
Seragen Diagnostics Inc. |
Soluble insoluble polymers in enzymeimmunoassay
|
FR2550799B1
(en)
*
|
1983-08-17 |
1986-02-21 |
Commissariat Energie Atomique |
COMPOUND MARKED BY AN ENZYME, ITS PREPARATION METHOD AND ITS USE IN ENZYMOIMMUNOLOGY
|
WO1985002260A1
(en)
*
|
1983-11-08 |
1985-05-23 |
Quidel |
Rapid plunger immunoassay method and apparatus
|
US4777240A
(en)
*
|
1984-03-08 |
1988-10-11 |
Scripps Clinic And Research Foundation |
SV40 expression vector containing HBxAg as an expression marker
|
US4645828A
(en)
|
1984-03-23 |
1987-02-24 |
Oncogen |
Platelet related growth regulator
|
US4665020A
(en)
*
|
1984-05-30 |
1987-05-12 |
United States Department Of Energy |
Flow cytometer measurement of binding assays
|
US4812396A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4812395A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
US4824784A
(en)
*
|
1985-04-08 |
1989-04-25 |
Hygeia Sciences, Incorporated |
Chromogenic solution for immunoassay
|
US4837395A
(en)
*
|
1985-05-10 |
1989-06-06 |
Syntex (U.S.A.) Inc. |
Single step heterogeneous assay
|
US4931385A
(en)
*
|
1985-06-24 |
1990-06-05 |
Hygeia Sciences, Incorporated |
Enzyme immunoassays and immunologic reagents
|
US4868108A
(en)
*
|
1985-12-12 |
1989-09-19 |
Hygeia Sciences, Incorporated |
Multiple-antibody detection of antigen
|
CH670709A5
(en)
*
|
1986-04-24 |
1989-06-30 |
Univ Moskovsk |
|
US5334513A
(en)
*
|
1988-05-17 |
1994-08-02 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5039607A
(en)
*
|
1988-05-17 |
1991-08-13 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5102788A
(en)
*
|
1988-11-21 |
1992-04-07 |
Hygeia Sciences, Inc. |
Immunoassay including lyophilized reactant mixture
|
US5135863A
(en)
*
|
1988-12-23 |
1992-08-04 |
Syntex (U.S.A.) Inc. |
Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
WO1992020820A1
(en)
*
|
1991-05-15 |
1992-11-26 |
Vanderbilt University |
Method to determine metastatic potential of tumor cells
|
US5348867A
(en)
*
|
1991-11-15 |
1994-09-20 |
George Georgiou |
Expression of proteins on bacterial surface
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US5801005A
(en)
*
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US6953573B1
(en)
*
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
AU679008B2
(en)
*
|
1993-05-06 |
1997-06-19 |
Chiron Diagnostics Corporation |
Mixed luminescent conjugate test assays
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5698686A
(en)
*
|
1994-10-20 |
1997-12-16 |
Arch Development Corporation |
Yeast telomerase compositions
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5858661A
(en)
*
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5807552A
(en)
*
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
US6689757B1
(en)
|
1996-02-12 |
2004-02-10 |
M.L. Laboratories Plc |
Methods for vaccination and vaccines therefor
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
IL127938A
(en)
|
1996-07-08 |
2002-09-12 |
Burstein Lab Inc |
Cleavable signal element device for diagnostic applications and assay method
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
EP1009753B1
(en)
*
|
1997-08-21 |
2005-04-20 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
CA2307345A1
(en)
|
1997-10-17 |
1999-04-29 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
US7605149B1
(en)
|
1998-07-13 |
2009-10-20 |
University Of South Florida |
Modulation of the phospholipase A2 pathway as a therapeutic
|
AU5080699A
(en)
*
|
1998-07-21 |
2000-02-14 |
Burstein Laboratories, Inc. |
Optical disc-based assay devices and methods
|
DE69836493T2
(en)
|
1998-07-22 |
2007-09-06 |
Syntron Bioresearch, Inc., Carlsbad |
DEVICE FOR DETERMINING SEVERAL ANALYTES
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
EP1117762A4
(en)
*
|
1998-09-29 |
2004-02-25 |
Gamida Cell Ltd |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
US6656471B1
(en)
|
1998-11-17 |
2003-12-02 |
Board Of Regents, The University Of Texas System |
HIV-specific T-cell induction
|
EP2311938B1
(en)
*
|
1999-02-04 |
2016-04-06 |
Pluristem Ltd. |
Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
EP1374889A1
(en)
*
|
1999-06-25 |
2004-01-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inducing angiogenesis by micro-organs
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US7167615B1
(en)
|
1999-11-05 |
2007-01-23 |
Board Of Regents, The University Of Texas System |
Resonant waveguide-grating filters and sensors and methods for making and using same
|
NZ519043A
(en)
*
|
1999-11-19 |
2006-12-22 |
Yissum Res Dev Co |
Nucleic acid comprising a gene derived from Aspergillus niger that encodes a polypeptide that has a beta-glucosidase catalytic activity
|
US6544506B2
(en)
*
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
EP1252292A4
(en)
*
|
2000-01-24 |
2004-11-17 |
Univ Ramot |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
DE60142475D1
(en)
|
2000-03-27 |
2010-08-12 |
Technion Res And Dev Of Founda |
UNIFORM CLASS I (MHC-I) UNIFORM MAJOR HISTORICITY COMPATIBILITY COMPOUNDS, ENCODING CONSTRUCTS, AND METHODS OF THEIR PRODUCTION
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(en)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Artifical vascular grafts, and methods of producing and using same
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US20030114410A1
(en)
*
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
DK1315519T3
(en)
|
2000-08-08 |
2011-04-11 |
Technion Res & Dev Foundation |
Pharmaceutical compositions and methods that can be used to treat cancer or liver fibrosis
|
EP1683874A3
(en)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
IL155097A0
(en)
*
|
2000-09-28 |
2003-10-31 |
Nanocyte Inc |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
AU1120102A
(en)
*
|
2000-11-02 |
2002-05-15 |
Univ Singapore |
AopB gene, protein, homologs, fragments and variants thereof, and their use for cell surface display
|
CA2429342C
(en)
|
2000-11-17 |
2013-03-19 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
JP4162486B2
(en)
|
2000-11-24 |
2008-10-08 |
ヴァスキュラー バイオジェニックス リミテッド |
Methods using defined oxidized phospholipids and compositions containing such oxidized phospholipids for preventing and treating atherosclerosis
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
AU2085502A
(en)
|
2000-11-30 |
2002-06-11 |
Molecular Skincare Ltd |
Diagnosis and treatment of disease
|
US20040052769A1
(en)
*
|
2000-11-30 |
2004-03-18 |
Yair Reisner |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
US20020142287A1
(en)
*
|
2000-12-14 |
2002-10-03 |
Hirotaka Yamamoto |
High throughput assay to detect inhibitors of the map kinase pathway
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
WO2002060376A2
(en)
*
|
2001-01-31 |
2002-08-08 |
Tolaren |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
WO2003087827A2
(en)
|
2001-04-11 |
2003-10-23 |
Burstein Technologies, Inc. |
Multi-parameter assays including analysis discs and methods relating thereto
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
IL159944A0
(en)
*
|
2001-07-19 |
2004-06-20 |
Yissum Res Dev Co |
Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
CA2458640A1
(en)
|
2001-08-16 |
2003-03-06 |
Bar-Ilan University |
Diagnosis, prevention and treatment of cancer
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
EP2277887A3
(en)
|
2001-10-19 |
2011-02-16 |
Vascular Biogenics Ltd. |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
|
AUPR842501A0
(en)
*
|
2001-10-23 |
2001-11-15 |
Epipop Pty Ltd |
A method for identification and development of therapeutic agents
|
US6867005B2
(en)
|
2001-10-24 |
2005-03-15 |
Beckman Coulter, Inc. |
Method and apparatus for increasing the dynamic range and accuracy of binding assays
|
US6696254B2
(en)
|
2001-11-21 |
2004-02-24 |
Kimberly-Clark Worldwide, Inc. |
Detection and identification of enteric bacteria
|
WO2003048298A2
(en)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
EP1465982A4
(en)
*
|
2002-01-25 |
2006-06-07 |
Gamida Cell Ltd |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
WO2005000193A2
(en)
|
2003-06-30 |
2005-01-06 |
Tel Aviv University Future Technology Development L.P. |
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
|
US6992176B2
(en)
*
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
CA2476625A1
(en)
*
|
2002-02-20 |
2003-08-28 |
Dyax Corp. |
Mhc-peptide complex binding ligands
|
SI2508596T1
(en)
|
2002-02-21 |
2016-01-29 |
Institute Of Virology Slovak Academy Of Sciences |
MN/CA IX-specific monoclonal antibodies generated from MN/CA IX-deficient mice and methods of use
|
EP1485464A4
(en)
*
|
2002-03-18 |
2006-11-29 |
Gamida Cell Ltd |
Methods of inducing differentiation in ex vivo expanded stem cells
|
AU2003215878A1
(en)
*
|
2002-03-26 |
2003-10-08 |
Nanocyte Inc. |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
|
ATE437235T1
(en)
*
|
2002-04-16 |
2009-08-15 |
Univ California |
METHOD FOR PROGNOSIS OF RENAL CELL CARCINOMA AND TREATMENT SELECTION WITH CARBOANHYDRASE IX
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
AU2003242967A1
(en)
*
|
2002-07-12 |
2004-02-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method and device for inducing biological processes by micro-organs
|
EP1524989B1
(en)
|
2002-08-01 |
2013-11-06 |
Yeda Research And Development Co., Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
AP2005003234A0
(en)
|
2002-08-20 |
2005-03-31 |
Genitrix Llc |
Lectin compositions and methods for modulating an immune response to an antigen.
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
CA2504512A1
(en)
|
2002-10-30 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Molecules and methods using same for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
US7947499B2
(en)
*
|
2002-11-29 |
2011-05-24 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
PT1583512E
(en)
|
2002-12-12 |
2011-01-27 |
R B T Rakuto Bio Technologies Ltd |
Use of lignin peroxidase in skin and hair lightening
|
CA2508880C
(en)
|
2002-12-16 |
2018-02-06 |
Technion Research And Development Foundation Ltd. |
Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
|
US7847084B2
(en)
|
2002-12-20 |
2010-12-07 |
Board Of Regents, The University Of Texas System |
VMP-like sequences of pathogenic Borrelia species and strains
|
JP2006512079A
(en)
|
2003-01-02 |
2006-04-13 |
ラッパポート・ファミリー・インスティチュート・フォー・リサーチ・イン・ザ・メディカル・サイエンシズ |
A method to predict the effectiveness of antioxidant therapy to prevent heart disease in hyperglycemic patients
|
DE602004020179D1
(en)
*
|
2003-01-07 |
2009-05-07 |
Univ Ramot |
PEPTIDENOUS RESOURCES CONTAINING EXTERNAL MATERIAL, AND METHOD FOR THE PRODUCTION THEREOF
|
AU2004243690A1
(en)
*
|
2003-03-03 |
2004-12-09 |
Burstein Technologies, Inc. |
Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
|
WO2004078991A2
(en)
|
2003-03-04 |
2004-09-16 |
Yeda Research And Development Co. Ltd. |
Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
|
EP1601759A4
(en)
*
|
2003-03-07 |
2007-02-14 |
Gamida Cell Ltd |
Expansion of renewable stem cell populations using modulators of pi 3-kinase
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
ES2433440T3
(en)
|
2003-04-04 |
2013-12-11 |
Yeda Research And Development Co. Ltd. |
Antibodies against MMP2 or MMP9 and pharmaceutical compositions containing the same useful for inhibiting the activity of said metalloproteins
|
CA2520023C
(en)
|
2003-04-08 |
2013-02-05 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to sdf-1 and methods of generating and using same
|
FR2853551B1
(en)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
CN1820020B
(en)
*
|
2003-05-06 |
2010-04-28 |
技术持有有限公司 |
SARS-coronavirus virus-like particles and methods of use
|
CN101942449B
(en)
|
2003-05-22 |
2014-07-02 |
伊沃基因有限公司 |
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
EP1635765B1
(en)
|
2003-05-23 |
2013-07-17 |
Board Of Regents, The University Of Texas System |
Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US20070041971A1
(en)
*
|
2003-07-07 |
2007-02-22 |
Wagner David H |
Methods for predicting development of auto-immune diseases and treatment of same
|
BRPI0412978A
(en)
*
|
2003-08-14 |
2006-10-03 |
Bio Balance Corp |
biologically pure bacterial group culture, bacterial coculture, therapeutic composition, food additive or supplement, foodstuff, method for treating or preventing disorder and article of manufacture
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
SI1678209T1
(en)
|
2003-10-07 |
2011-07-29 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
BRPI0415742A
(en)
*
|
2003-10-23 |
2006-12-19 |
Pfizer Producs Inc |
vaccine for periodontal disease
|
ATE447412T1
(en)
|
2003-11-04 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES AND METHODS OF USE
|
ATE476991T1
(en)
|
2003-11-04 |
2010-08-15 |
Novartis Vaccines & Diagnostic |
METHOD FOR TREATING SOLID TUMORS WITH EXPRESSION OF CD40 CELL SURFACE ANTIGEN
|
DE602004028272D1
(en)
|
2003-11-04 |
2010-09-02 |
Novartis Vaccines & Diagnostic |
USE OF ANTAGONIST ANTI-CD40 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF MULTIPLE MYELOMA
|
US20070110754A1
(en)
|
2003-11-04 |
2007-05-17 |
Chiron Corporation |
Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia
|
WO2005051423A2
(en)
|
2003-11-30 |
2005-06-09 |
Yeda Research And Development Co. Ltd |
Methods and agents for immune modulation and methods for identifying immune modulators
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
DK1722834T3
(en)
|
2003-12-22 |
2012-10-22 |
Regentis Biomaterials Ltd |
Matrix, which includes naturally occurring cross-linked protein skeleton
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
EP2816351A3
(en)
*
|
2004-01-27 |
2015-03-25 |
Compugen Ltd. |
Methods and systems for annotating biomolecular sequences
|
AU2005219441A1
(en)
|
2004-03-02 |
2005-09-15 |
Acceleron Pharma Inc. |
ALK7 and myostatin inhibitors and uses thereof
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
ES2635546T3
(en)
|
2004-06-14 |
2017-10-04 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in the development of plant fiber and methods of use thereof
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
EP2295974A1
(en)
|
2004-09-08 |
2011-03-16 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Compositions and methods for the detection of HIV-1/HIV-2 infection
|
EP1799812A4
(en)
*
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
US20060095241A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US8000900B2
(en)
|
2004-09-21 |
2011-08-16 |
Microsoft Corporation |
Association-based predictions of pathogen characteristics
|
EP2357241B1
(en)
|
2004-09-29 |
2015-03-04 |
Collplant Ltd. |
Collagen producing plants and methods of generating and using same
|
ES2524601T3
(en)
*
|
2004-09-29 |
2014-12-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Recombinant human T2 RNase and uses thereof
|
EP1809374A4
(en)
*
|
2004-10-12 |
2008-09-10 |
Closed Loop Therapies Ltd |
Methods and implantable devices for treating supraventricular arrhythmias
|
US8478535B2
(en)
|
2004-10-29 |
2013-07-02 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US20090118132A1
(en)
*
|
2004-11-04 |
2009-05-07 |
Roche Molecular Systems, Inc. |
Classification of Acute Myeloid Leukemia
|
US7842794B2
(en)
|
2004-12-17 |
2010-11-30 |
Roche Molecular Systems, Inc. |
Reagents and methods for detecting Neisseria gonorrhoeae
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
EP1872604A4
(en)
*
|
2005-01-16 |
2010-01-20 |
Zlango Ltd |
Communications network system and methods for using same
|
EP1844403A4
(en)
*
|
2005-01-16 |
2010-06-23 |
Zlango Ltd |
Iconic communication
|
WO2007080558A2
(en)
*
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Communications network system and methods for using same
|
EP3028765B1
(en)
|
2005-01-31 |
2020-01-08 |
Realbio Technologies Ltd. |
Method of sequentially transferring liquids through a lateral flow capillary device
|
JP4992091B2
(en)
|
2005-02-17 |
2012-08-08 |
ハダシット メディカル リサーチ サービシーズ アンド デベロップメント リミテッド |
Bisphosphonates for treating endometriosis
|
US8216801B2
(en)
|
2005-02-25 |
2012-07-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center |
Methods for treating inflammatory disorders
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
US20090068207A1
(en)
*
|
2005-04-15 |
2009-03-12 |
Vascular Biogenics Ltd. |
Compositions Containing Beta 2-Glycoprotein I-Derived Peptides for the Prevention and/or Treatment of Vascular Disease
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
US8333970B2
(en)
|
2005-05-18 |
2012-12-18 |
Novartis Ag |
Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject having an inflammatory or autoimmune disease
|
US9943481B2
(en)
|
2005-05-26 |
2018-04-17 |
Biorest Ltd. |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
EP2465924A3
(en)
|
2005-06-16 |
2013-01-02 |
Ramot at Tel-Aviv University Ltd. |
Isolated cells and populations comprising same for the treament of cns diseases
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
US20060292559A1
(en)
*
|
2005-06-23 |
2006-12-28 |
Beckman Coulter, Inc. |
Cell-based microarrays, and methods for their preparation and use
|
JP5383186B2
(en)
*
|
2005-07-07 |
2014-01-08 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム リミテッド |
Nucleic acid agents that down-regulate H19 and methods of using the same
|
JP5086254B2
(en)
|
2005-07-07 |
2012-11-28 |
フルクルム エスピー リミテッド |
SP1 polypeptides, modified SP1 polypeptides and uses thereof
|
EP1904638A2
(en)
|
2005-07-18 |
2008-04-02 |
Metabogal Ltd. |
Mucosal or enteral administration of biologically active macromolecules
|
JP5017269B2
(en)
|
2005-07-26 |
2012-09-05 |
ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ |
Antibody profile specific to tuberculosis
|
AU2006278260B2
(en)
*
|
2005-08-08 |
2012-03-08 |
Onconon, Llc. |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
US8916147B2
(en)
|
2005-08-24 |
2014-12-23 |
Yeda Research and Devolpment Co. Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
EP1962719A4
(en)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
Media for culturing stem cells
|
US8034914B2
(en)
*
|
2005-09-22 |
2011-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
BRPI0618965B1
(en)
|
2005-10-24 |
2021-01-12 |
Evogene Ltd |
method to increase a plant's tolerance to an abiotic stress condition, method to increase a plant's biomass, vigor and / or yield, method to increase the efficiency of fertilizer use and / or absorption of a plant
|
BRPI0620523A2
(en)
|
2005-11-29 |
2011-11-16 |
Gamida Cell Ltd |
method of increasing implant potential and cell attraction, method of preparing cells for transplantation in a subject, cell population and pharmaceutical composition
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
EP1977312A2
(en)
|
2006-01-16 |
2008-10-08 |
Zlango Ltd. |
Iconic communication
|
EP1998800A2
(en)
|
2006-01-18 |
2008-12-10 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2007092252A2
(en)
|
2006-02-03 |
2007-08-16 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
BRPI0706967A2
(en)
|
2006-02-06 |
2011-04-12 |
Rappaport Family Inst For Res |
method and kit for diagnosing dmt1
|
US8343733B2
(en)
|
2006-03-06 |
2013-01-01 |
Zetiq Technologies Ltd. |
Methods and compositions for identifying a cell phenotype
|
CA2646384C
(en)
|
2006-03-23 |
2020-03-24 |
Pluristem Ltd. |
Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
|
WO2007110869A2
(en)
|
2006-03-28 |
2007-10-04 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to warfarin resistance
|
WO2007118214A2
(en)
*
|
2006-04-07 |
2007-10-18 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Antibody compositions and methods for treatment of neoplastic disease
|
SMP200800064B
(en)
|
2006-04-21 |
2009-11-06 |
Novartis Ag |
Pharmaceutical compositions of anti-cd40 antagonist antibodies
|
ZA200810677B
(en)
*
|
2006-05-19 |
2010-03-31 |
Teva Pharma |
Fusion proteins, uses thereof and processes for producing same
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
US8629259B2
(en)
|
2006-07-20 |
2014-01-14 |
Yeda Research And Development Co. Ltd. |
Photosynthetic organisms and compositions and methods of generating same
|
US8809052B2
(en)
|
2006-08-28 |
2014-08-19 |
Yeda Research And Development Co. Ltd. |
Methods of generating mature oligodendrocytes
|
US20080138840A1
(en)
*
|
2006-09-08 |
2008-06-12 |
Collins Michael T |
Assay for antibodies to mycobacterium paratuberculosis
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
ES2426754T3
(en)
|
2006-10-05 |
2013-10-25 |
Technion Research & Development Foundation Ltd. |
Microtubes and methods to produce them
|
MX2009006660A
(en)
*
|
2006-12-20 |
2009-08-20 |
Evogene Ltd |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same.
|
GB0700133D0
(en)
|
2007-01-04 |
2007-02-14 |
Humabs Llc |
Human cytomegalovirus neutralising antibodies and use thereof
|
CA2675964C
(en)
*
|
2007-01-16 |
2015-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
H19 silencing nucleic acid agents for treating rheumatoid arthritis
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
US8911996B2
(en)
|
2007-01-31 |
2014-12-16 |
Technion Research & Development Foundation Limited |
Electrospun scaffolds and methods of generating and using same
|
US8546333B2
(en)
|
2007-02-01 |
2013-10-01 |
Technion Research & Development Foundation Limited |
Albumin fibers and fabrics and methods of generating and using same
|
JP5377330B2
(en)
|
2007-02-02 |
2013-12-25 |
ベイラー リサーチ インスティテュート |
Vaccine based on targeting of antigen to DCIR expressed on antigen presenting cells
|
TWI422594B
(en)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)
|
EP2684889A3
(en)
*
|
2007-02-02 |
2014-03-05 |
Baylor Research Institute |
Multivariable antigens complexed with targeting humanized monoclonal antibody
|
CN102586186A
(en)
*
|
2007-02-23 |
2012-07-18 |
贝勒研究院 |
Activation of human antigen-presenting cells through CLEC-6
|
JP2010519316A
(en)
|
2007-02-23 |
2010-06-03 |
ベイラー リサーチ インスティテュート |
Application of activation of human antigen-presenting cells via dectin-1 to therapy
|
BRPI0807563A2
(en)
*
|
2007-02-23 |
2014-07-01 |
Baylor Res Inst |
CELL ACTIVATION PRESENTING HUMAN ANTIGEN THROUGH Oxidized LDL RECEPTOR-1 (LOX-1) SIMILAR TO DENDRITIC CELL LECTIN
|
US8748371B2
(en)
|
2007-02-28 |
2014-06-10 |
Yeda Research And Development Co. Ltd. |
Nuclear targeting sequences
|
CA2682093A1
(en)
|
2007-03-29 |
2008-10-09 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
JP2010523104A
(en)
|
2007-04-02 |
2010-07-15 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
Cancer cell detection method and use thereof for diagnosis of cancer disease and monitoring of treatment of cancer disease
|
MX355608B
(en)
*
|
2007-04-09 |
2018-04-24 |
Evogene Ltd |
Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants.
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2014064687A1
(en)
|
2012-10-22 |
2014-05-01 |
Deliversir Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
ES2516827T3
(en)
*
|
2007-04-23 |
2014-10-31 |
Deliversir Ltd |
A system to deliver therapeutic agents to living cells and cell nuclei
|
EP3032259B1
(en)
|
2007-05-01 |
2020-04-15 |
Tel Hashomer Medical Research Infrastructure and Services Ltd. |
Methods for detecting trophoblast cells in maternal blood based on cytokeratin-7
|
ES2846400T3
(en)
|
2007-05-03 |
2021-07-28 |
Agency For Science Tech And Research Astarstar |
Antibodies that bind to an intracellular PRL-1 or PRL-3 polypeptide
|
EP3366762B1
(en)
|
2007-05-07 |
2020-07-08 |
Protalix Ltd. |
Large scale disposable bioreactor
|
EP2500428A3
(en)
|
2007-07-11 |
2012-12-26 |
Yeda Research and Development Co. Ltd. |
Nucleic acid construct systems capable of diagnosing or treating a cell state
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
CA2696833A1
(en)
|
2007-07-15 |
2009-01-22 |
Yitzchak Hillman |
Disease treatment via antimicrobial peptides or their inhibitors
|
ES2547305T3
(en)
*
|
2007-07-24 |
2015-10-05 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded by them, and methods of using them to increase tolerance to abiotic stress and / or biomass and / or yield in plants that express them
|
ES2402334T3
(en)
*
|
2007-08-02 |
2013-04-30 |
Gilead Biologics, Inc |
Procedures and compositions for the treatment and diagnosis of fibrosis
|
RU2474433C2
(en)
|
2007-08-15 |
2013-02-10 |
ЙЕДА РЕСЕАРЧ ЭНД ДЕВЕЛОПМЕНТ КО. ЛТД, эт ве Вайзманн Институте оф Сайнсе |
Mmp-9 regulators and use thereof
|
WO2009072001A2
(en)
*
|
2007-09-12 |
2009-06-11 |
Aurelium Biopharma Inc. |
Slc9a3r1 directed diagnostics for neoplastic disease
|
CN101855549A
(en)
|
2007-09-12 |
2010-10-06 |
耶达研究及发展有限公司 |
Methods of treating tumors in immune-privileged sites
|
KR101738285B1
(en)
|
2007-09-19 |
2017-05-29 |
플루리스템 리미티드 |
Composition for treating ischemia comprising adherent cells from placenta tissue
|
US8088735B2
(en)
|
2007-10-19 |
2012-01-03 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
|
WO2009059328A2
(en)
*
|
2007-11-02 |
2009-05-07 |
The Johns Hopkins University |
Multi- component l2 vaccine for prevention of human papillomavirus infection
|
JP2011504374A
(en)
|
2007-11-26 |
2011-02-10 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド |
Composition comprising fibrous polypeptide and polysaccharide
|
US20110119791A1
(en)
|
2007-12-27 |
2011-05-19 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
CA2713667A1
(en)
*
|
2008-01-31 |
2009-08-06 |
Compugen Ltd. |
Cd55 isoform and uses therof in cancer detection, monitoring and therapy
|
US9464368B2
(en)
|
2008-02-21 |
2016-10-11 |
Technion Research & Development Foundation Ltd. |
Methods of attaching a molecule-of-interest to a microtube
|
US8153383B2
(en)
*
|
2008-03-18 |
2012-04-10 |
Wisconsin Alumni Research Foundation |
Mycobacterial culture screening test for Mycobacterium avium complex bacteria
|
US20110033473A1
(en)
*
|
2008-04-09 |
2011-02-10 |
Yoram Reiter |
Anti influenza antibodies and uses thereof
|
WO2009125394A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anti human immunodeficiency antibodies and uses thereof
|
CN102083615B
(en)
*
|
2008-04-10 |
2014-08-13 |
战略系统有限公司 |
System and method for three dimensional model printing
|
CN102056619A
(en)
|
2008-04-18 |
2011-05-11 |
科尔普兰特有限公司 |
Methods of generating and using procollagen
|
EP2936976A1
(en)
|
2008-04-21 |
2015-10-28 |
Danziger Innovations Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
EP2116618A1
(en)
|
2008-05-09 |
2009-11-11 |
Agency for Science, Technology And Research |
Diagnosis and treatment of Kawasaki disease
|
EP2279258B1
(en)
*
|
2008-05-22 |
2018-03-28 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility
|
RU2515156C2
(en)
|
2008-05-27 |
2014-05-10 |
Плуристем Лтд. |
Methods of treating inflammatory diseases of colon
|
EP2620493B1
(en)
|
2008-05-28 |
2019-03-27 |
Ramot at Tel Aviv University Ltd. |
Mesenchymal stem cells for the treatment of CNS diseases
|
CN102076415B
(en)
|
2008-06-29 |
2015-06-24 |
瑞尔比奥技术有限公司 |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
UA106354C2
(en)
|
2008-07-16 |
2014-08-26 |
Инститьют Фо Рисерч Ин Байомедсин |
Human cytomegalovirus neutralizing antibodies and use thereof
|
EP2303923B1
(en)
|
2008-07-16 |
2015-06-24 |
Institute for Research in Biomedicine |
Human cytomegalovirus neutralising antibodies and use thereof
|
NZ590628A
(en)
|
2008-07-16 |
2012-03-30 |
Baylor Res Inst |
Hiv vaccine based on targeting maximized gag and nef to dendritic cells
|
CA2733218A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
EP2320953B1
(en)
|
2008-08-08 |
2015-07-15 |
Genisphere, LLC |
Long-acting dna dendrimers and methods thereof
|
CN102176914B
(en)
|
2008-08-08 |
2014-12-17 |
新加坡科技研究局 |
VHZ for diagnosis and treatment of cancers
|
US9018445B2
(en)
|
2008-08-18 |
2015-04-28 |
Evogene Ltd. |
Use of CAD genes to increase nitrogen use efficiency and low nitrogen tolerance to a plant
|
MX2011002328A
(en)
|
2008-09-02 |
2011-05-19 |
Pluristem Ltd |
Adherent cells from placenta tissue and use thereof in therapy.
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
WO2010029545A2
(en)
|
2008-09-11 |
2010-03-18 |
Ben Gurion University Of The Negev Research And Development Authority |
Compositions and methods for treating s. pneumoniae infection
|
WO2010031006A1
(en)
|
2008-09-12 |
2010-03-18 |
Cryopraxis Criobiologia Ltda. |
Ischemic tissue cell therapy
|
EP2789626B1
(en)
|
2008-09-24 |
2018-07-18 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US20110178024A1
(en)
|
2008-09-29 |
2011-07-21 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
JP2012504660A
(en)
|
2008-10-06 |
2012-02-23 |
ユニバーシティ オブ シカゴ |
Compositions and methods related to bacterial EAP, EMP and / or ADSA proteins
|
CA2736350C
(en)
|
2008-10-30 |
2021-06-22 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
WO2010055525A1
(en)
|
2008-11-17 |
2010-05-20 |
Technion Research & Development Foundation Ltd. |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
WO2010064247A1
(en)
|
2008-12-03 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
ES2442168T3
(en)
|
2008-12-05 |
2014-02-10 |
Yeda Research And Development Co. Ltd. |
Diagnostic methods of motor neuron diseases
|
WO2010071610A1
(en)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Severe chikungunya biomarkers
|
US20120009148A1
(en)
|
2008-12-29 |
2012-01-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
|
MX340023B
(en)
|
2008-12-29 |
2016-06-22 |
Evogene Ltd |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same.
|
SG172244A1
(en)
|
2008-12-29 |
2011-07-28 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US8455263B2
(en)
|
2008-12-30 |
2013-06-04 |
Jin Po Lee |
Quantitative analyte assay device and method
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
US9107935B2
(en)
*
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
EP2391377A2
(en)
|
2009-02-02 |
2011-12-07 |
Ramot at Tel-Aviv University Ltd. |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
US20110311494A1
(en)
|
2009-02-26 |
2011-12-22 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of reprogramming renal cells
|
CA2999342C
(en)
|
2009-03-02 |
2021-08-17 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
WO2010103515A2
(en)
|
2009-03-09 |
2010-09-16 |
Ramot At Tel Aviv University Ltd. |
Compositions and methods for prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
DK2414542T3
(en)
|
2009-03-30 |
2017-11-27 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
PROCEDURES FOR PREDICTING CLINICAL PROCEDURE AND TREATMENT OF MULTIPLE SCLEROSIS
|
JP2012522762A
(en)
|
2009-04-01 |
2012-09-27 |
ザ メディカル リサーチ, インフラストラクチャー, アンド ヘルス サーヴィシーズ ファンド オブ ザ テル アヴィヴ メディカル センター |
Methods for regulating keratinocyte proliferation and differentiation
|
DK3281947T3
(en)
|
2009-04-03 |
2020-05-11 |
Univ Chicago |
Compositions and Methods Related to Protein A (SPA) Variants
|
WO2011127032A1
(en)
|
2010-04-05 |
2011-10-13 |
University Of Chicago |
Compositions and methods related to protein a (spa) antibodies as an enhancer of immune response
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
US8598322B2
(en)
|
2009-04-30 |
2013-12-03 |
Tel Hashomer Medical Research Infrastucture and Services Ltd. |
Anti CEACAM1 antibodies and methods of using same
|
CN102576024B
(en)
|
2009-05-19 |
2016-10-26 |
泽蒂克科技有限公司 |
The test kit of the differential staining of cervical cancer cell and/or tissue and method
|
WO2010135663A2
(en)
|
2009-05-21 |
2010-11-25 |
The United States Of America , As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for the detection of hiv-1/hiv-2 infection
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
EP2435072A2
(en)
|
2009-05-27 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Proteasome inhibitors and uses thereof
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
BRPI1009032B1
(en)
|
2009-06-10 |
2019-05-28 |
Evogene Ltd. |
METHOD OF INCREASED EFFICIENCY IN THE USE OF NITROGEN, BIOMASS, GROWTH RATE, AND / OR TOLERANCE THE DEFICIENCY OF NITROGEN OF A PLANT
|
IN2012DN00715A
(en)
|
2009-06-24 |
2015-06-19 |
Health Corp Rambam |
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
AU2010274581B2
(en)
|
2009-07-21 |
2014-05-01 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
A method of diagnosing cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
US20120148546A1
(en)
|
2009-08-17 |
2012-06-14 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
EP2467162A4
(en)
*
|
2009-08-21 |
2013-10-02 |
Gilead Biologics Inc |
Therapeutic methods and compositions
|
CN102713601A
(en)
*
|
2009-08-21 |
2012-10-03 |
吉联亚生物科技有限公司 |
In vitro screening assays
|
US8512990B2
(en)
|
2009-08-21 |
2013-08-20 |
Gilead Biologics, Inc. |
Catalytic domains from lysyl oxidase and LOXL2
|
US20110044907A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Derek Marshall |
In vivo screening assays
|
NZ625850A
(en)
*
|
2009-08-21 |
2015-12-24 |
Gilead Biologics Inc |
Methods and compositions for treatment of pulmonary fibrotic disorders
|
AU2010286111A1
(en)
|
2009-08-21 |
2012-02-16 |
Beeologics Inc. |
Preventing and curing beneficial insect diseases via plant transcribed molecules
|
US9642817B2
(en)
|
2009-08-27 |
2017-05-09 |
Technion Research & Development Foundation Limited |
Liposomal compositions and uses of same
|
WO2011030332A2
(en)
|
2009-09-08 |
2011-03-17 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
EP2475784A1
(en)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
WO2011030329A1
(en)
|
2009-09-10 |
2011-03-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
EP2478093A2
(en)
|
2009-09-17 |
2012-07-25 |
Yeda Research and Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2011033511A1
(en)
|
2009-09-17 |
2011-03-24 |
Ramot At Tel-Aviv University Ltd. |
Peptides for the treatment of oxidative stress related disorders
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
EP3272869B1
(en)
|
2009-10-14 |
2020-06-24 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. |
Compositions for controlling varroa mites in bees
|
US9109206B2
(en)
|
2009-10-16 |
2015-08-18 |
Rutgers, The State University Of New Jersey |
Method for treating chronic nerve tissue injury using a cell therapy strategy
|
WO2011048600A1
(en)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
Knock-out mouse of the mo-1 gene, a gene associated with morbid obesity
|
EP3633025B1
(en)
|
2009-11-12 |
2022-09-14 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
US8962561B2
(en)
|
2009-11-12 |
2015-02-24 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
WO2011061736A1
(en)
|
2009-11-17 |
2011-05-26 |
Protalix Ltd. |
Alkaline alpha galactosidase for the treatment of fabry disease
|
US20130183326A9
(en)
|
2009-11-20 |
2013-07-18 |
St. Jude Children's Research Hospital |
Methods and compositions for modulating the activity of the interleukin-35 receptor complex
|
WO2011064773A1
(en)
|
2009-11-24 |
2011-06-03 |
Collplant Ltd. |
Method of generating collagen fibers
|
EP2977445B1
(en)
|
2009-11-30 |
2018-07-25 |
Pluristem Ltd. |
Adherent cells from placenta and use of same in disease treatment
|
US9562235B2
(en)
|
2009-12-06 |
2017-02-07 |
A.B. Seeds Ltd. |
MicroRNA compositions and methods for enhancing plant resistance to abiotic stress
|
EP2862929B1
(en)
|
2009-12-09 |
2017-09-06 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for treating diseases, disorders or injury of the CNS
|
US9493785B2
(en)
|
2009-12-28 |
2016-11-15 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
EP3184109B1
(en)
|
2009-12-29 |
2020-11-18 |
Gamida-Cell Ltd. |
Methods for enhancing natural killer cell proliferation and activity
|
KR101754437B1
(en)
|
2010-01-05 |
2017-07-05 |
바스큘라 바이오제닉스 리미티드 |
Methods for use of a specific anti-angiogenic adenoviral agent
|
US20130052165A1
(en)
|
2010-01-12 |
2013-02-28 |
Livnat Bangio |
Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
|
CN102822202B
(en)
|
2010-01-27 |
2015-07-22 |
耶达研究及发展有限公司 |
Antibodies that inhibit metalloproteins
|
RU2549684C2
(en)
|
2010-02-04 |
2015-04-27 |
Джилид Байолоджикс, Инк. |
Antibodies binding to lysyl oxidase-like enzyme-2 (loxl2), and method for preparing them
|
WO2011099006A2
(en)
|
2010-02-11 |
2011-08-18 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
EP2538961B1
(en)
|
2010-02-24 |
2016-10-12 |
Ben Gurion University Of The Negev Research And Development Authority |
Inhibition of necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
WO2011111034A1
(en)
|
2010-03-08 |
2011-09-15 |
Yeda Research And Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
CA2790211C
(en)
|
2010-03-08 |
2020-06-09 |
Monsanto Technology Llc |
Methods and compositions for delivering polynucleotides into plants
|
WO2011111050A2
(en)
|
2010-03-11 |
2011-09-15 |
Jacob Edrei |
Methods of generating hydrogen
|
EP2556085A2
(en)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Protease-activatable pore-forming polypeptides
|
EP2557913B1
(en)
|
2010-04-12 |
2016-08-03 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
WO2011128897A1
(en)
|
2010-04-12 |
2011-10-20 |
Technion Research & Development Foundation Ltd. |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
JP5858984B2
(en)
|
2010-04-18 |
2016-02-10 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Molecules for treating diseases related to ErbB / ErbB ligands and methods of using the molecules
|
MX344729B
(en)
|
2010-04-28 |
2017-01-05 |
Evogene Ltd |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics.
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
US9352000B2
(en)
|
2010-05-05 |
2016-05-31 |
Rappaport Family Institute For Research In The Medical Sciences |
Use of CCL1 in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
CA2799307C
(en)
|
2010-05-13 |
2019-07-02 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
CN103037891A
(en)
|
2010-06-03 |
2013-04-10 |
雷蒙特亚特特拉维夫大学有限公司 |
Methods of treating diabetes and compositions capable of same
|
EP2576829A1
(en)
|
2010-06-07 |
2013-04-10 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
US20130097731A1
(en)
|
2010-06-16 |
2013-04-18 |
Futuragene Israel Ltd. |
Pest-resistant plants containing a combination of a spider toxin and a chitinase
|
WO2011158243A2
(en)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
CA2803298C
(en)
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
WO2012007945A2
(en)
|
2010-07-12 |
2012-01-19 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Isolated polynucleotides and methods and plants using same for regulating plant acidity
|
CA2805479A1
(en)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and glutamic acid decarboxylase (gad) autoantigenic peptides
|
EP2593480A2
(en)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
CA2804728A1
(en)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Nucleic acid construct for increasing abiotic stress tolerance in plants
|
CA2804914A1
(en)
|
2010-07-22 |
2012-01-26 |
Nadir Askenasy |
Regulatory immune cells with enhanced targeted cell death effect
|
WO2012014208A2
(en)
|
2010-07-27 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Methods and systems for assessing clonality of cell cultures
|
WO2012014207A2
(en)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
EP2600885A2
(en)
|
2010-08-04 |
2013-06-12 |
Ramot at Tel Aviv University, Ltd. |
Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
|
EP2606122A1
(en)
|
2010-08-22 |
2013-06-26 |
Ramot at Tel Aviv University, Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
CA3158003A1
(en)
|
2010-08-30 |
2012-03-08 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
ES2746482T3
(en)
|
2010-09-07 |
2020-03-06 |
Technion Res & Dev Foundation |
New methods and culture media to cultivate pluripotent stem cells
|
WO2012032520A1
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
BR112013005756A2
(en)
|
2010-09-08 |
2018-12-26 |
Yeda Research And Development Co. Ltd |
use of anti third party central memory t cells for anti-leukemia / lymphoma treatment
|
SG188471A1
(en)
|
2010-09-08 |
2013-04-30 |
Yeda Res & Dev |
An immunosuppressive drug combination for a stable and long term engraftment
|
WO2012034067A1
(en)
|
2010-09-09 |
2012-03-15 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
WO2012035539A1
(en)
|
2010-09-15 |
2012-03-22 |
Ramot At Tel-Aviv University Ltd. |
Methods of expanding and redifferentiating islet beta cells
|
WO2012038956A1
(en)
|
2010-09-20 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
EP3075396A1
(en)
|
2010-10-17 |
2016-10-05 |
Yeda Research and Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
WO2012056452A2
(en)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
EP2632956B1
(en)
|
2010-10-28 |
2018-06-20 |
Yeda Research and Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
UY33705A
(en)
|
2010-11-03 |
2012-04-30 |
Yissum Res Dev Co |
TRANSGENIC PLANTS WITH IMPROVED SACARIFICATION PERFORMANCES AND METHODS TO GENERATE THEM
|
EP2635105B1
(en)
|
2010-11-04 |
2017-12-20 |
Ben-Gurion University of The Negev Research and Development Authority |
Acyl-coa: diacylglycerol acyltransferase 1-like gene (ptdgat1) and uses thereof
|
CN103298826A
(en)
|
2010-11-15 |
2013-09-11 |
特拉维夫大学拉莫特有限公司 |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
US10117895B2
(en)
|
2010-11-17 |
2018-11-06 |
Ben-Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
WO2012075111A1
(en)
|
2010-11-30 |
2012-06-07 |
Novartis Ag |
Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers
|
US9574171B2
(en)
|
2010-12-02 |
2017-02-21 |
Technion Research & Development Foundation Ltd. |
Methods of generating corneal cells and cell populations comprising same
|
US20120183960A1
(en)
|
2010-12-07 |
2012-07-19 |
Enterologics, Inc. |
Method for identifying e. coli m-17
|
CA2816495C
(en)
|
2010-12-15 |
2020-10-13 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
AU2011346525B2
(en)
|
2010-12-22 |
2016-04-28 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for improving plant properties
|
SG191768A1
(en)
|
2010-12-28 |
2013-08-30 |
Kamedis Ltd |
Plant extracts for the treatment and prevention of infections
|
ES2774190T3
(en)
|
2011-01-20 |
2020-07-17 |
Protalix Ltd |
Alpha-galactosidase compositions
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
WO2012114339A1
(en)
|
2011-02-23 |
2012-08-30 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
EP2492279A1
(en)
|
2011-02-25 |
2012-08-29 |
Laboratorios Del. Dr. Esteve, S.A. |
Rapid immunogen selection method using lentiviral display
|
UA113843C2
(en)
|
2011-03-02 |
2017-03-27 |
|
BACTERIA TRANSGENIC PLANT CONTAINING T3SS DIFFUNCTIONAL PROTEINS
|
EP2680864B1
(en)
|
2011-03-03 |
2019-05-08 |
Ramot at Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
MX346663B
(en)
|
2011-03-06 |
2017-03-27 |
Merck Serono Sa |
Low fucose cell lines and uses thereof.
|
WO2012120518A1
(en)
|
2011-03-08 |
2012-09-13 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (pku)
|
EP2686348B1
(en)
|
2011-03-17 |
2015-12-30 |
Ramot at Tel-Aviv University Ltd. |
Bi- and monospecific, asymmetric antibodies and methods of generating the same
|
EP2685976B1
(en)
|
2011-03-17 |
2017-12-27 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
KR101903339B1
(en)
|
2011-03-22 |
2018-10-01 |
플루리스템 리미티드 |
Methods for treating radiation or chemical injury
|
US20140045764A1
(en)
|
2011-03-24 |
2014-02-13 |
Neurim Pharmaceuticals (1991) Ltd. |
Neuroprotective peptides
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
ES2627154T3
(en)
|
2011-04-06 |
2017-07-26 |
Ramot At Tel-Aviv University Ltd. |
Methods of monitoring and analysis of metabolic activity profiles, diagnostic and therapeutic uses thereof
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
CN103476924A
(en)
|
2011-04-15 |
2013-12-25 |
普拉里斯坦有限公司 |
Methods and systems for harvesting cells
|
BR122020018201B1
(en)
|
2011-05-03 |
2021-11-09 |
Evogene Ltd |
METHODS TO INCREASE YIELD, BIOMASS, GROWTH RATE, STRENGTH, OIL CONTENT, FIBER YIELD, FIBER QUALITY, ABIOTIC STRESS TOLERANCE AND/OR EFFICIENCY IN THE USE OF NITROGEN IN A PLANT TO GENERATE A PLANT NUCLEIC ACID CONSTRUCT
|
US9192670B2
(en)
|
2011-05-04 |
2015-11-24 |
Ramot At Tel-Aviv University Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
EP3263127B1
(en)
|
2011-05-23 |
2019-08-21 |
Yeda Research and Development Co. Ltd |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
KR102211724B1
(en)
|
2011-05-31 |
2021-02-03 |
허치슨 바이오필름 메디컬 솔루션스 리미티드 |
Dispersion and detachment of cell aggregates
|
WO2012164565A1
(en)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
US9415103B2
(en)
|
2011-06-14 |
2016-08-16 |
Yeda Research And Development Co. Ltd. |
Combination therapy to prevent DCIS formation and progression to breast cancer
|
CN103906428A
(en)
|
2011-06-23 |
2014-07-02 |
凯伊玛生物农业科技有限公司 |
Common wheat, plants or parts thereof having partially or fully multiplied genome, hybrids and products thereof and methods of generating and using same
|
JP6035332B2
(en)
|
2011-07-18 |
2016-11-30 |
インスティテュート・フォー・リサーチ・イン・バイオメディシンInstitute For Research In Biomedicine |
Influenza A virus neutralizing antibody and method of use thereof
|
BR112014001348A2
(en)
|
2011-07-20 |
2017-07-18 |
Kaiima Bio Agritech Ltd |
partially or fully multiplied maize plants and their uses
|
US20130030452A1
(en)
|
2011-07-27 |
2013-01-31 |
Health Corporation - Rambam |
Devices for surgical applications
|
HUE033746T2
(en)
|
2011-08-04 |
2018-01-29 |
Yeda Res & Dev |
Mir-135 and compositions comprising same for the treatment of serotonin associated medical conditions
|
EP2741753A2
(en)
|
2011-08-09 |
2014-06-18 |
Yeda Research and Development Co. Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
US20140212568A1
(en)
|
2011-08-14 |
2014-07-31 |
Kaiimam Bio Agritech Ltd. |
Durum wheat plants having a partially or fully multiplied genome and uses thereof
|
WO2013035070A1
(en)
|
2011-09-07 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Olfactory signature and odorant mixture having the same
|
CN103930130B
(en)
|
2011-09-08 |
2016-07-06 |
耶达研究及发展有限公司 |
Anti-third party's central type memory T cell, its production method and its application in transplanting and disease treatment
|
WO2013035071A1
(en)
|
2011-09-08 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Novel risk biomarkers for lung cancer
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013040057A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
AU2012308659B2
(en)
|
2011-09-13 |
2017-05-04 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
MX361938B
(en)
|
2011-09-13 |
2018-12-19 |
Monsanto Technology Llc |
Methods and compositions for weed control.
|
MX362810B
(en)
|
2011-09-13 |
2019-02-13 |
Monsanto Technology Llc |
Methods and compositions for weed control.
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
HUE035999T2
(en)
|
2011-10-21 |
2018-06-28 |
Augurex Life Sciences Corp |
Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
|
WO2013061328A2
(en)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Method of treating cancer
|
MX356814B
(en)
|
2011-11-03 |
2018-06-13 |
Quark Pharmaceuticals Inc |
Methods and compositions for neuroprotection.
|
US20140323549A1
(en)
|
2011-11-08 |
2014-10-30 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
WO2013076729A1
(en)
|
2011-11-23 |
2013-05-30 |
Danziger Dan Flower Farm |
Otomeria plants
|
US9617331B2
(en)
|
2011-11-27 |
2017-04-11 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
|
JP2015500279A
(en)
|
2011-12-08 |
2015-01-05 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Mammalian fetal lung cells and therapeutic use of the cells
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
WO2013093920A2
(en)
|
2011-12-22 |
2013-06-27 |
Yeda Research And Development Co. Ltd. |
A combination therapy for a stable and long term engraftment
|
US20130164193A1
(en)
|
2011-12-22 |
2013-06-27 |
Life Technologies Corporation |
Sequential lateral flow capillary device for analyte determination
|
CN104270939A
(en)
|
2011-12-28 |
2015-01-07 |
凯伊玛生物农业科技有限公司 |
Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
|
SG11201403756PA
(en)
|
2012-01-01 |
2014-11-27 |
Qbi Entpr Ltd |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
WO2013114371A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dry powder formulations of dnase i
|
US10184131B2
(en)
|
2012-02-06 |
2019-01-22 |
A.B. Seeds Ltd. |
Isolated polynucleotides expressing or modulating microRNAs or targets of same, transgenic plants comprising same and uses thereof
|
CA2863795A1
(en)
|
2012-02-13 |
2013-08-22 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells
|
SG11201404836QA
(en)
|
2012-02-14 |
2014-12-30 |
Opko Biolog Ltd |
Long-acting coagulation factors and methods of producing same
|
CN104245725A
(en)
|
2012-02-19 |
2014-12-24 |
波塔力克斯有限公司 |
Oral unit dosage forms and uses of same for the treatment of gaucher disease
|
JP2015509366A
(en)
|
2012-02-22 |
2015-03-30 |
ブレインステム バイオテック リミテッド |
Generation of neural stem cells and motor neurons
|
JP6329911B2
(en)
|
2012-02-22 |
2018-05-23 |
ブレインステム バイオテック リミテッド |
MicroRNA for the production of astrocytes
|
EP2833714A1
(en)
|
2012-03-01 |
2015-02-11 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
EP2822971B1
(en)
|
2012-03-07 |
2018-07-18 |
Yeda Research and Development Co. Ltd. |
Compositions for inhibition of quiescin sulfhydryl oxidase (qsox1) and uses of same
|
DK2828293T3
(en)
|
2012-03-20 |
2018-01-08 |
Humabs Biomed S A |
ANTIBODIES NEUTRALIZING RSV, MPV AND PVM AND USE THEREOF
|
WO2013140389A1
(en)
|
2012-03-22 |
2013-09-26 |
Ramot At Tel-Aviv University Ltd. |
Plif multimeric peptides and uses thereof
|
US9283272B2
(en)
|
2012-03-30 |
2016-03-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Targeting intracellular target-binding determinants with intracellular antibodies
|
CN104271749A
(en)
|
2012-04-18 |
2015-01-07 |
雷蒙特亚特特拉维夫大学有限公司 |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
EA201491898A1
(en)
|
2012-04-19 |
2015-08-31 |
Опко Байолоджикс Лтд. |
OPTIONS OF OXINTOMODULIN PROLONGED ACTION AND METHODS OF OBTAINING THE SPECIFIED OPTIONS
|
EP2841084B1
(en)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer
|
JP6670106B2
(en)
|
2012-04-26 |
2020-03-18 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
Staphylococcal coagulase antigen and method of use
|
ES2627816T3
(en)
|
2012-05-09 |
2017-07-31 |
Yeda Research And Development Co. Ltd. |
Variants of the pro-domain of tace as a TNF-a inhibitor and its medical use
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
US9290564B2
(en)
|
2012-05-24 |
2016-03-22 |
Mountgate Group Limited |
Compositions and methods related to the prevention and treatment of rabies infection
|
AU2013264742B2
(en)
|
2012-05-24 |
2018-10-04 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
WO2013183048A1
(en)
|
2012-06-03 |
2013-12-12 |
Ben-Gurion University Of The Negev Research And Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
SG11201408054RA
(en)
|
2012-06-04 |
2015-01-29 |
Opko Biolog Ltd |
Pegylated oxm variants
|
US10023474B2
(en)
|
2012-07-03 |
2018-07-17 |
Nanospun Technologies Ltd. |
Methods for adsorption and biodegradation of petroleum
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US10155933B2
(en)
|
2012-07-29 |
2018-12-18 |
Yeda Research And Development Co., Ltd. |
Use of the reductive glycine pathway for generating formatotrophic and autotrophic microorganisms
|
EP2879678B1
(en)
|
2012-07-31 |
2023-03-01 |
Yeda Research and Development Co. Ltd. |
Enoxacin for treating amyotrophic lateral sclerosis
|
WO2014024183A1
(en)
|
2012-08-06 |
2014-02-13 |
Brainstorm Cell Therapeutics Ltd. |
Methods of generating mesenchymal stem cells which secrete neurotrophic factors
|
EP2698377A1
(en)
|
2012-08-17 |
2014-02-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Enhanced rapid immunogen selection method for HIV gp120 variants
|
AR092868A1
(en)
|
2012-09-03 |
2015-05-06 |
A B Seeds Ltd |
METHOD FOR IMPROVING TOLERANCE TO THE ABIOTIC STRESS OF PLANTS AND PLANTS GENERATED THROUGH SUCH METHOD
|
EP2895197B1
(en)
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
EP2900685B1
(en)
|
2012-09-27 |
2017-10-25 |
Research Development Foundation |
Attenuated chikungunya virus
|
US11105809B2
(en)
|
2012-10-09 |
2021-08-31 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
US20150266970A1
(en)
|
2012-10-24 |
2015-09-24 |
Yeda Research And Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
US9926564B2
(en)
|
2012-10-29 |
2018-03-27 |
Yeda Research And Development Co. Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
BR112015011583B1
(en)
|
2012-11-20 |
2023-03-14 |
Opko Biologics Ltd |
METHODS FOR INCREASE THE HYDRODYNAMIC SIZE OR VOLUME OF HUMAN GROWTH HORMONE, METHOD FOR INCREASE THE APPARENT MOLECULAR WEIGHT OF A POLYPEPTIDE, AND METHOD FOR INCREASE THE HALF-LIFE OF A POLYPEPTIDE
|
MX2015004626A
(en)
|
2012-11-29 |
2015-07-14 |
Yeda Res & Dev |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors.
|
US10041068B2
(en)
|
2013-01-01 |
2018-08-07 |
A. B. Seeds Ltd. |
Isolated dsRNA molecules and methods of using same for silencing target molecules of interest
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
CA2894472C
(en)
|
2013-01-17 |
2021-08-17 |
Novellusdx Ltd. |
Methods and systems for identifying patient specific driver mutations
|
EP2950808B1
(en)
|
2013-02-04 |
2019-08-21 |
Ramot at Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
CA2904035A1
(en)
|
2013-03-06 |
2014-09-12 |
Protalix Ltd. |
Tnf alpha inhibitor polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
|
EP2964669B1
(en)
|
2013-03-06 |
2018-09-12 |
Protalix Ltd. |
Use of plant cells expressing a tnfalpha polypeptide inhibitor in therapy
|
EP2964254B1
(en)
|
2013-03-07 |
2019-09-18 |
University of Maryland, Baltimore |
Immunotherapeutic potential of modified lipooligosaccharides/lipid a
|
US10609930B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP2967082A4
(en)
|
2013-03-13 |
2016-11-02 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CA2907680A1
(en)
|
2013-03-21 |
2014-09-25 |
Collplant Ltd. |
Compositions comprising collagen and prp for tissue regeneration
|
WO2014155376A1
(en)
|
2013-03-24 |
2014-10-02 |
Biokine Therapeutics Ltd. |
Methods of treating myeloid leukemia
|
CA2909380A1
(en)
|
2013-04-21 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Agents for downregulation of the activity and/or amount of bcl-xl and/or bcl-w
|
ES2831424T3
(en)
|
2013-04-23 |
2021-06-08 |
Yeda Res & Dev |
Isolated naive pluripotent stem cells and methods to generate them
|
ES2671002T3
(en)
|
2013-04-25 |
2018-06-04 |
Yeda Research And Development Co., Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
WO2014188423A1
(en)
|
2013-05-21 |
2014-11-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
CA2912997C
(en)
|
2013-05-27 |
2021-09-07 |
Rakuto Bio Technologies Ltd. |
Enzymatic system-containing cosmetic compositions
|
ES2938044T3
(en)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Omentum-based structure and delivery system
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
EP3030663B1
(en)
|
2013-07-19 |
2019-09-04 |
Monsanto Technology LLC |
Compositions and methods for controlling leptinotarsa
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
US9938316B2
(en)
|
2013-08-29 |
2018-04-10 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants composed of cellular scaffolds and a vascular pedicle
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
WO2015040609A1
(en)
|
2013-09-17 |
2015-03-26 |
Yeda Research And Development Co. Ltd. |
Erk-derived peptides and uses thereof
|
EP3052191B1
(en)
|
2013-10-01 |
2020-03-18 |
Kadimastem Ltd. |
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)
|
CN113667012B
(en)
|
2013-10-02 |
2024-07-12 |
免疫医疗有限责任公司 |
Neutralizing anti-influenza A antibodies and uses thereof
|
EP3060239B1
(en)
|
2013-10-21 |
2020-05-13 |
OPKO Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
ES2811804T3
(en)
|
2013-10-31 |
2021-03-15 |
Biokine Therapeutics Ltd |
A peptide inhibitor of CXCR4 for use in the treatment of acute myeloid leukemia with an FLT3 mutation
|
NZ719544A
(en)
|
2013-11-04 |
2022-09-30 |
Beeologics Inc |
Compositions and methods for controlling arthropod parasite and pest infestations
|
CA2925698C
(en)
|
2013-11-28 |
2021-11-09 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Rna polymerase i inhibitors and uses thereof
|
EP3074044A2
(en)
|
2013-11-28 |
2016-10-05 |
Yeda Research and Development Co., Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
DK3080243T3
(en)
|
2013-12-10 |
2019-01-07 |
Yeda Res & Dev |
USE OF ENZYMES THAT CATALYZE PYRUVATH SYNTHESIS FROM FORMIATE AND ACETYL COA, AND BACTERIES THAT EXPRESS THIS
|
UA119253C2
(en)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Compositions and methods for virus control in varroa mite and bees
|
BR112016016337A2
(en)
|
2014-01-15 |
2017-10-03 |
Monsanto Technology Llc |
COMPOSITION AND METHODS FOR CONTROLLING THE GROWTH, DEVELOPMENT OR REPRODUCTION ABILITY OF A PLANT, AND FOR SENSITIZING A PLANT TO AN EPSPS-INHIBITOR HERBICIDIER
|
WO2015114633A1
(en)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
|
EP3102192A2
(en)
|
2014-02-03 |
2016-12-14 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Use of casein kinase i inhibitors for depleting stem cells
|
JP2017506228A
(en)
|
2014-02-05 |
2017-03-02 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
MicroRNA for the treatment and diagnosis of serotonin releasing hormone, adrenergic releasing hormone, noradrenaline releasing hormone, glutamate releasing hormone and corticotropin releasing hormone related medical conditions and compositions comprising said microRNA
|
ES2696348T3
(en)
|
2014-02-06 |
2019-01-15 |
Yeda Res & Dev |
Anti-CD84 antibodies, compositions comprising the same and uses thereof
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
JP6628253B2
(en)
|
2014-02-11 |
2020-01-08 |
ブレインストーム セル セラペウティクス リミテッド |
Method for determining cell suitability
|
EP3114483A1
(en)
|
2014-03-03 |
2017-01-11 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Method and device for detection of pseudomonas aeruginosa
|
EP2923709A1
(en)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Multi-component-multistage malaria vaccine
|
WO2015153339A2
(en)
|
2014-04-01 |
2015-10-08 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
EP3129075A4
(en)
|
2014-04-10 |
2017-12-06 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
WO2015159292A2
(en)
|
2014-04-14 |
2015-10-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A method and kit for determining the tissue or cell origin of dna
|
WO2015159295A1
(en)
|
2014-04-17 |
2015-10-22 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
MD20160130A2
(en)
|
2014-04-27 |
2017-04-30 |
Ccam Biotherapeutics Ltd. |
Humanized antibodies against CEACAM1
|
WO2015166492A2
(en)
|
2014-04-28 |
2015-11-05 |
Yeda Research And Development Co. Ltd. |
Microbiome response to agents
|
KR20170005829A
(en)
|
2014-05-04 |
2017-01-16 |
포레스트 이노베이션스 엘티디. |
Compositions for mosquito control and uses of same
|
JP6836500B2
(en)
|
2014-05-16 |
2021-03-03 |
ベイラー リサーチ インスティテュートBaylor Research Institute |
Methods and compositions for treating autoimmune and inflammatory conditions
|
EP3145947A2
(en)
|
2014-05-22 |
2017-03-29 |
Yeda Research and Development Co., Ltd. |
Recombinant microorganisms capable of carbon fixation
|
WO2015186129A1
(en)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
WO2015186128A1
(en)
|
2014-06-02 |
2015-12-10 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
EP3158067B1
(en)
|
2014-06-23 |
2020-08-12 |
Monsanto Technology LLC |
Compositions and methods for regulating gene expression via rna interference
|
US20170183376A1
(en)
|
2014-06-24 |
2017-06-29 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
EP3161138A4
(en)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
US10883994B2
(en)
|
2014-06-25 |
2021-01-05 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Identification of cancer stem cells markers and use of same for diagnosis and treatment
|
US10583084B2
(en)
|
2014-06-26 |
2020-03-10 |
Ramot At Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
BR112017000710B1
(en)
|
2014-07-15 |
2024-02-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
ISOLATED POLYPEPTIDE, COMPOSITION OF MATTER, AND, USE OF THE ISOLATED POLYPEPTIDE OR COMPOSITION OF MATTER
|
WO2016011035A2
(en)
|
2014-07-15 |
2016-01-21 |
Medlmmune, Llc |
Neutralizing anti-influenza b antibodies and uses thereof
|
CA2955411A1
(en)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Methods for determining drug response of patient specific mutations
|
US11015229B2
(en)
|
2014-07-21 |
2021-05-25 |
Novellusdx Ltd. |
Methods and systems for determining oncogenic index of patient specific mutations
|
RU2754955C2
(en)
|
2014-07-29 |
2021-09-08 |
Монсанто Текнолоджи Ллс |
Compositions and methods for combating insect pests
|
US11920164B2
(en)
|
2014-07-30 |
2024-03-05 |
Yeda Research And Development Co. Ltd. |
Media for culturing naive human pluripotent stem cells
|
CN107076746B
(en)
|
2014-08-14 |
2020-05-29 |
米密德诊断学有限公司 |
Computer analysis of biological data using manifolds and hyperplanes
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
US10526416B2
(en)
|
2014-09-08 |
2020-01-07 |
Yeda Research And Development Co. Ltd. |
Anti-HER3 antibodies and uses of same
|
EP2992895A1
(en)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Three-component-multistage malaria vaccine
|
JP2017534574A
(en)
|
2014-09-08 |
2017-11-24 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
Compositions and methods for treating cancer resistant to tyrosine kinase inhibitors (TKI)
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
Nmda receptor antagonists for treating gaucher disease
|
WO2016042561A2
(en)
|
2014-09-21 |
2016-03-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating mir-132 for the treatment of lipid related disorders
|
WO2016055950A1
(en)
|
2014-10-08 |
2016-04-14 |
Novartis Ag |
Combination of human cytomegalovirus neutralizing antibodies
|
AU2015336079C1
(en)
|
2014-10-20 |
2020-12-17 |
Gen-Probe Incorporated |
Red blood cell lysis solution
|
WO2016075697A1
(en)
|
2014-11-13 |
2016-05-19 |
Enzootic Holdings Ltd. |
Functional sex-reversal of decapod crustacean females
|
WO2016075546A2
(en)
|
2014-11-14 |
2016-05-19 |
Antonio Lanzavecchia |
Antibodies that neutralize ebola virus and uses thereof
|
US20180042994A1
(en)
|
2014-11-17 |
2018-02-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
US20190102512A1
(en)
|
2014-11-17 |
2019-04-04 |
Yeda Research And Development Co., Ltd. |
Method of analyzing microbiome
|
EP3220947B1
(en)
|
2014-11-18 |
2020-10-28 |
Humabs Biomed S.A. |
Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof
|
WO2016079739A2
(en)
|
2014-11-20 |
2016-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
|
JP6860483B2
(en)
|
2014-11-26 |
2021-04-14 |
テクノロジー イノベーション モメンタム ファンド(イスラエル)リミテッド パートナーシップTechnology Innovation Momentum Fund(israel)Limited Partnership |
Bacterial gene targeting reduction
|
JP2017535296A
(en)
|
2014-11-27 |
2017-11-30 |
ダンツィガー イノベイションズ リミテッドDanziger Innovations Ltd. |
Nucleic acid constructs for genome editing
|
WO2016092555A2
(en)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
US11891622B2
(en)
|
2014-12-30 |
2024-02-06 |
Cell Cure Neurosciences Ltd. |
RPE cell populations and methods of generating same
|
CA3175175A1
(en)
|
2014-12-30 |
2016-07-07 |
Cell Cure Neurosciences Ltd. |
Methods of treating retinal diseases
|
ES2880346T3
(en)
|
2014-12-30 |
2021-11-24 |
Cell Cure Neurosciences Ltd |
Evaluation of retinal pigment epithelial cell populations
|
US11225648B2
(en)
|
2015-01-04 |
2022-01-18 |
Protalix Ltd. |
Modified DNase and uses thereof
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
WO2016118762A1
(en)
|
2015-01-22 |
2016-07-28 |
Monsanto Technology Llc |
Compositions and methods for controlling leptinotarsa
|
US20180345047A1
(en)
|
2015-02-26 |
2018-12-06 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
WO2016142948A1
(en)
|
2015-03-11 |
2016-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Anti amphiregulin antibodies, compositions comprising same and uses thereof
|
EP3273971A4
(en)
|
2015-03-27 |
2018-12-05 |
Yeda Research and Development Co. Ltd. |
Methods of treating motor neuron diseases
|
ES2904573T3
(en)
|
2015-03-27 |
2022-04-05 |
Univ Southern California |
LHR-directed T cell therapy for the treatment of solid tumors
|
US20180071369A1
(en)
|
2015-03-31 |
2018-03-15 |
Yeda Research And Development Co. Ltd. |
Glutamate oxaloacetate transaminase 1 (got1), preparations and methods of generating same and uses thereof
|
EP3277260B1
(en)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
DK3280401T3
(en)
|
2015-04-07 |
2021-11-15 |
Ela Pharma Ltd |
COMPOSITIONS FOR THE TREATMENT AND / OR PREVENTION OF CELL OR TISSUE CROSS SPECIFICALLY DIRECTED AT KATHEPSIN C AND / OR CELA1 AND / OR CELA3A AND / OR STRUCTURELY RELATED
|
EP3081575A1
(en)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium parasite antibodies
|
EP3288547B1
(en)
|
2015-04-27 |
2023-06-07 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Egr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
EP3288386B1
(en)
|
2015-04-29 |
2022-01-19 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Anti-phytopathogenic compositions
|
WO2016174652A1
(en)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
US11845928B2
(en)
|
2015-05-04 |
2023-12-19 |
Tsinghua University |
Methods and kits for fragmenting DNA
|
US20180161300A1
(en)
|
2015-05-11 |
2018-06-14 |
Yeda Research And Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
US11219636B2
(en)
|
2015-05-17 |
2022-01-11 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
WO2016185481A2
(en)
|
2015-05-20 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
WO2016185469A1
(en)
|
2015-05-21 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Bacterial populations for promoting health
|
JP2018517697A
(en)
|
2015-05-29 |
2018-07-05 |
オプコ バイオロジクス リミテッド |
PEGylated oxyntomodulin mutant
|
RS62446B1
(en)
|
2015-06-01 |
2021-11-30 |
Medimmune Llc |
Neutralizing anti-influenza binding molecules and uses thereof
|
CN107750125A
(en)
|
2015-06-02 |
2018-03-02 |
孟山都技术有限公司 |
For by the composition and method in delivery of polynucleotides to plant
|
AU2016270913A1
(en)
|
2015-06-03 |
2018-01-04 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
CA2987992A1
(en)
|
2015-06-04 |
2016-12-08 |
University Of Southern California |
Lym-1 and lym-2 targeted car cell immunotherapy
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
WO2016203477A1
(en)
|
2015-06-18 |
2016-12-22 |
Yeda Research And Development Co. Ltd. |
Conditioning protocols and use of same for tissue regeneration
|
CN113289009A
(en)
|
2015-06-19 |
2021-08-24 |
Opko生物科学有限公司 |
Long-acting coagulation factor and production method thereof
|
WO2016207402A1
(en)
|
2015-06-26 |
2016-12-29 |
Institute For Research In Biomedicine |
Proteins comprising a mutated lair-1 fragment and uses thereof
|
DK3322425T3
(en)
|
2015-07-16 |
2023-06-12 |
Yeda Res & Dev |
GENETICLY MODIFIED ANTI-THIRD PARTY CENTRAL MEMORY T CELLS AND THE USE OF THE SAME IN IMMUNE THERAPY
|
WO2017009843A2
(en)
|
2015-07-16 |
2017-01-19 |
Biokine Therapeutics Ltd. |
Compositions, articles of manufacture and methods for treating cancer
|
EP3325494B1
(en)
|
2015-07-19 |
2020-12-30 |
Yeda Research and Development Co., Ltd. |
Selective inhibitors of alpha2-containing isoforms of na,k-atpase and use thereof for reducing intraocular pressure
|
BR112018001310A2
(en)
|
2015-07-22 |
2018-09-11 |
Phytopharma Int Ltd |
bee-ingestible compositions, methods of use thereof for the production of honey and honey produced by these
|
ES2865024T3
(en)
|
2015-07-29 |
2021-10-14 |
Hadasit Med Res Service |
Large-scale production of retinal pigment epithelium cells
|
US20180221393A1
(en)
|
2015-08-03 |
2018-08-09 |
Biokine Therapeutics Ltd. |
Cxcr4 binding agents for treatment of diseases
|
US20180237774A1
(en)
|
2015-08-04 |
2018-08-23 |
Yeda Research And Development Co. Ltd. |
Methods of screening for riboswitches and attenuators
|
EA201890442A1
(en)
|
2015-08-05 |
2018-07-31 |
Селл Кьюр Нейросайансес Лтд. |
OBTAINING PHOTORECEPTORS FOR THE TREATMENT OF RETITAL DISEASES
|
DK3331994T3
(en)
|
2015-08-05 |
2022-11-21 |
Cell Cure Neurosciences Ltd |
PRODUCTION OF RETINAL PIGMENT EPITHELIAL CELLS
|
US10639350B2
(en)
|
2015-08-10 |
2020-05-05 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using CD24
|
US20180237790A1
(en)
|
2015-08-13 |
2018-08-23 |
Forrest Innovation Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042814A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Use of perforin positive immature dendritic cells in disease treatment
|
WO2017059878A1
(en)
|
2015-10-07 |
2017-04-13 |
Humabs Biomed Sa |
Antibodies that potently neutralize hepatitis b virus and uses thereof
|
EP3365376A1
(en)
|
2015-10-25 |
2018-08-29 |
Yeda Research and Development Co., Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
EP3368661A1
(en)
|
2015-10-26 |
2018-09-05 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CA3002767C
(en)
|
2015-10-27 |
2023-03-14 |
Zvi VOGEL |
Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method of inducing cardiomyocytes proliferation and treating heart diseases
|
US20180303974A1
(en)
|
2015-11-03 |
2018-10-25 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
WO2017081689A1
(en)
|
2015-11-11 |
2017-05-18 |
Ramot At Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
WO2017094001A1
(en)
|
2015-11-30 |
2017-06-08 |
Kadimastem Ltd |
Methods for differentiating and purifying pancreatic endocrine cells
|
EP3176183A1
(en)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
|
EP3389678B1
(en)
|
2015-12-16 |
2022-06-15 |
Ramot at Tel-Aviv University Ltd. |
Particles comprising decellularized omentum
|
EP3397344A4
(en)
|
2015-12-28 |
2019-08-28 |
B.G. Negev Technologies and Applications Ltd. at Ben-Gurion University |
Composition and method for treating amyotrophic lateral sclerosis
|
US10828318B2
(en)
|
2016-01-06 |
2020-11-10 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
EP3403091B1
(en)
|
2016-01-11 |
2021-12-22 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
EP3402513A4
(en)
|
2016-01-13 |
2019-10-23 |
Medlmmune, LLC |
Method of treating influenza a
|
BR112018014902A2
(en)
|
2016-01-21 |
2018-12-18 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
solenaceous parthenocarpic plants, fruits and seeds of a plant, edible processed products, methods of production and reproduction of a plant,
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
Composition comprising sp1 and carbon based nanoparticles and uses thereof
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive yarn
|
EP3408376A1
(en)
|
2016-01-31 |
2018-12-05 |
Hadasit Medical Research Services and Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
WO2017134671A1
(en)
|
2016-02-04 |
2017-08-10 |
Yeda Research And Development Co. Ltd. |
Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53
|
US20190046497A1
(en)
|
2016-02-14 |
2019-02-14 |
Yeda Research And Development Co., Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
ES2771223T3
(en)
|
2016-02-14 |
2020-07-06 |
Yeda Res & Dev |
Diagnosis, prediction and treatment of relapsing obesity based on the microbiome
|
CA3014889A1
(en)
|
2016-02-16 |
2017-08-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Non-protein phenylalanine analogues for inhibiting cyanobacteria and plant growth
|
JP2019511919A
(en)
|
2016-02-23 |
2019-05-09 |
ブローディ,チャヤ |
Production of cancer stem cells and use thereof
|
US10906987B2
(en)
|
2016-03-01 |
2021-02-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Antibodies specific to human poliovirus receptor (PVR)
|
IL294121B2
(en)
|
2016-03-03 |
2023-09-01 |
Memed Diagnostics Ltd |
Analyzing rna for diagnosing infection type
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods of isolating barrel-like proteases and identifying peptides processed thereby
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
CA3232826A1
(en)
|
2016-04-27 |
2017-11-02 |
Gen-Probe Incorporated |
Blood cell lysis reagent
|
EP3463402B1
(en)
|
2016-05-22 |
2021-06-23 |
Yeda Research and Development Co. Ltd. |
Methods of using pulmonary cells for transplantation and induction of tolerance
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of agents for treating drug resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
US11820833B2
(en)
|
2016-06-05 |
2023-11-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Peptides that inhibit binding of EPCR to its ligand to treat inflammation
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
EP3472342A1
(en)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
CN109661463B
(en)
|
2016-06-27 |
2023-04-04 |
耶达研究及发展有限公司 |
Reverse suppressor cells generated from memory T cells
|
CN109661578B
(en)
|
2016-07-10 |
2022-05-10 |
米密德诊断学有限公司 |
Protein characterization for differentiating bacterial and viral infections
|
EP4184167A1
(en)
|
2016-07-10 |
2023-05-24 |
MeMed Diagnostics Ltd. |
Early diagnosis of infections
|
US20190224244A1
(en)
|
2016-07-11 |
2019-07-25 |
Bonus Therapeutics Ltd. |
Cell compositions for tissue regeneration
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combination therapy to increase endogenous nitric oxide (no) synthesis
|
WO2018011805A2
(en)
|
2016-07-11 |
2018-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Systems and methods for growing cells in vitro
|
EA201990255A1
(en)
|
2016-07-11 |
2019-07-31 |
Опко Байолоджикс Лтд |
Blood clotting factor VII prolonged action and methods for its production
|
WO2018010789A1
(en)
|
2016-07-13 |
2018-01-18 |
Humabs Biomed Sa |
Novel antibodies specifically binding to zika virus epitopes and uses thereof
|
WO2018015881A1
(en)
|
2016-07-18 |
2018-01-25 |
Ramot At Tel-Aviv University Ltd. |
Modular platform for targeted therapeutics
|
WO2018020489A1
(en)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
EP3497231B1
(en)
|
2016-08-08 |
2023-10-04 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
EP3497239A4
(en)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Analysis of methylation status and copy number
|
CN109844532B
(en)
|
2016-08-10 |
2022-06-17 |
米密德诊断学有限公司 |
System and method for analyzing biological data
|
EP3496730B1
(en)
|
2016-08-14 |
2022-05-25 |
Ramot at Tel-Aviv University Ltd. |
Mesenchymal cell-derived exosomes to treat neurological disorders
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
JP2020501506A
(en)
|
2016-09-07 |
2020-01-23 |
イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー. |
Anti-NKp46 antibody and therapeutic use thereof
|
WO2018051347A1
(en)
|
2016-09-14 |
2018-03-22 |
Yeda Research And Development Co. Ltd. |
Crisp-seq, an integrated method for massively parallel single cell rna-seq and crispr pooled screens
|
EP3519833A4
(en)
|
2016-09-29 |
2020-06-03 |
MeMed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of a circadian rhythm disorder
|
US10662226B2
(en)
|
2016-10-28 |
2020-05-26 |
The Regents of the University of Caiifomia |
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
|
WO2018087759A1
(en)
|
2016-11-10 |
2018-05-17 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
EP3545095A1
(en)
|
2016-11-28 |
2019-10-02 |
Yeda Research and Development Co., Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
US20190343782A1
(en)
|
2016-11-30 |
2019-11-14 |
Yeda Research And Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
CN109689120A
(en)
|
2016-12-01 |
2019-04-26 |
拉莫特特拉维夫大学有限公司 |
Combination therapy for neurotrosis
|
US11555178B2
(en)
|
2017-01-18 |
2023-01-17 |
Yeda Research And Development Co. Ltd. |
Genetically modified veto cells and use of same in immunotherapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Isolated cells genetically modified to express a disarm system having an anti-phage activity and methods of producing same
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods of culturing t cells and uses of same
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
US20200150125A1
(en)
|
2017-03-12 |
2020-05-14 |
Yeda Research And Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
CN118021843A
(en)
|
2017-03-16 |
2024-05-14 |
谱系细胞疗法公司 |
Method for measuring efficacy of retinal disease therapy
|
JP2020516243A
(en)
|
2017-04-05 |
2020-06-11 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
Ex vivo culture system and method of using the same
|
EA201992434A1
(en)
|
2017-04-19 |
2020-03-30 |
Инститьют Фор Рисерч Ин Байомедисин |
NEW ANTI-MALARIA VACCINES AND ANTIBODIES RELATING TO PLASMODIA SPOROZOITES
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Methods of treating psychiatric stress disorders
|
KR20200004880A
(en)
|
2017-05-10 |
2020-01-14 |
아리엘 싸이언티픽 이노베이션스 엘티디. |
How to Purify Antibodies
|
US11714089B2
(en)
|
2017-05-21 |
2023-08-01 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Combination of markers for diagnosing cancer
|
WO2018216011A1
(en)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
EP3630973A1
(en)
|
2017-05-31 |
2020-04-08 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
EP3652342A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Detecting tissue-specific dna
|
US11466323B2
(en)
|
2017-07-13 |
2022-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Dual-probe digital droplet PCR strategy for specific detection of tissue-specific circulating DNA molecules
|
EP3652344A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Dna targets as tissue-specific methylation markers
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combination therapy for the treatment of cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against transferrin receptor 1 (tfr1)-tropic arenaviruses
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
WO2019042555A1
(en)
|
2017-08-31 |
2019-03-07 |
Humabs Biomed Sa |
Multispecific antibodies specifically binding to zika virus epitopes and uses thereof
|
SG11202002481RA
(en)
|
2017-09-19 |
2020-04-29 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing gene expression in eukaryotic cells
|
CN111587123A
(en)
|
2017-11-09 |
2020-08-25 |
品通治疗有限公司 |
Methods and compositions for generating and using humanized conformation-specific phosphorylated tau antibodies
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with improved properties
|
CA3083436A1
(en)
|
2017-11-29 |
2019-06-06 |
Weedout Ltd. |
Compositions, kits and methods for controlling weed of the amaranthus genus
|
EP3717032B1
(en)
|
2017-11-29 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Methods of preventing or treating neurogenic shock
|
WO2019106680A1
(en)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Treatment of an ischemic heart disease
|
WO2019116376A1
(en)
|
2017-12-17 |
2019-06-20 |
Yeda Research And Development Co. Ltd. |
Cop9 signalosome (csn) complex modulators and uses thereof
|
WO2019130313A1
(en)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method to reproduce circadian rhythms on a microfluidic chip
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Endoplasmic reticulum targeting signal
|
EP3749368A1
(en)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
EP3749689A1
(en)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Inhibitors of the 20s proteasome
|
WO2019162945A1
(en)
|
2018-02-23 |
2019-08-29 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
US20200408761A1
(en)
|
2018-02-28 |
2020-12-31 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
EP3765034A1
(en)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Treatment of a heart disease
|
WO2019183500A1
(en)
|
2018-03-23 |
2019-09-26 |
Hung Chiung Yu |
Coccidioides antigens and methods of their use
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
CN112236131A
(en)
|
2018-03-29 |
2021-01-15 |
技术研究及发展基金有限公司 |
Vesicles comprising PTEN inhibitors and uses thereof
|
EP3774047A1
(en)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Use of electric field gradients to control gene expression
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
AU2019277908A1
(en)
|
2018-05-27 |
2021-01-07 |
Biolinerx Ltd. |
AGI-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
EP3800998A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
EP3802839A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
EP3810636A1
(en)
|
2018-06-25 |
2021-04-28 |
Yeda Research and Development Co. Ltd |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
WO2020012467A2
(en)
|
2018-07-08 |
2020-01-16 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
US20210214417A1
(en)
|
2018-07-11 |
2021-07-15 |
Kahr Medical Ltd. |
SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF
|
US11912790B2
(en)
|
2018-07-11 |
2024-02-27 |
Immunity Pharma Ltd. |
Peptide compounds and therapeutic uses of same
|
CN112823208A
(en)
|
2018-07-31 |
2021-05-18 |
科弗朗有限公司 |
Tobacco transgenic events and methods for detecting and using tobacco transgenic events
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
JP2021535100A
(en)
|
2018-08-24 |
2021-12-16 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
Methods and Treatments for Modulating M2 Macrophage Polarization
|
CN113038951B
(en)
|
2018-09-20 |
2024-04-30 |
耶达研究及发展有限公司 |
Method for treating amyotrophic lateral sclerosis
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
HUE063732T2
(en)
|
2018-12-19 |
2024-01-28 |
Humabs Biomed Sa |
Antibodies that neutralize hepatitis b virus and uses thereof
|
EP3914698A1
(en)
|
2019-01-23 |
2021-12-01 |
Yeda Research and Development Co. Ltd |
Culture media for pluripotent stem cells
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
Anti-matrix metalloproteinase 7 (mmp-7) inhibitory antibody and uses thereof
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
WO2020170240A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reduction drug-induced nephrotoxicity
|
EP3927807A1
(en)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
US20220136003A1
(en)
|
2019-03-05 |
2022-05-05 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Genome-edited birds
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
US20220175920A1
(en)
|
2019-03-27 |
2022-06-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Recombinant proteins with cd40 activating properties
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
EP3946611A2
(en)
|
2019-03-31 |
2022-02-09 |
Yeda Research and Development Co. Ltd |
Anti-viral and anti-tumoral compounds
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
US20220220559A1
(en)
|
2019-05-13 |
2022-07-14 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutated neopeptides
|
CA3140611A1
(en)
|
2019-05-22 |
2020-11-26 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
CA3140406A1
(en)
|
2019-05-28 |
2020-12-03 |
Shanghaitech University |
Composition and methods to treat ectodermal dysplasia 2, clouston type
|
EP3983531A1
(en)
|
2019-06-12 |
2022-04-20 |
Hadasit Medical Research Services and Development Ltd. |
Methods of generating oligodendrocytes
|
WO2020255124A1
(en)
|
2019-06-16 |
2020-12-24 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
EP3990488A4
(en)
|
2019-06-27 |
2023-09-13 |
Ramot at Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
CA3145972A1
(en)
|
2019-07-04 |
2021-01-07 |
Ukko Inc. |
De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
|
MX2022000367A
(en)
|
2019-07-11 |
2022-07-13 |
Kahr Medical Ltd |
Heterodimers and methods of use thereof.
|
WO2021009740A1
(en)
|
2019-07-16 |
2021-01-21 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
CA3147575A1
(en)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Methods of treating and diagnosing lung cancer
|
CA3148950A1
(en)
|
2019-07-30 |
2021-02-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
EP4014046A1
(en)
|
2019-08-12 |
2022-06-22 |
Yeda Research and Development Co. Ltd |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
US20240140988A1
(en)
|
2019-08-22 |
2024-05-02 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
WO2021038569A1
(en)
|
2019-08-27 |
2021-03-04 |
Yeda Research And Development Co. Ltd. |
Treatment of bacterial vaginosis
|
MX2022002231A
(en)
|
2019-08-29 |
2022-03-22 |
Vir Biotechnology Inc |
Antibody compositions and methods for treating hepatitis b virus infection.
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembly of protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
EP4051695A1
(en)
|
2019-10-31 |
2022-09-07 |
Yeda Research and Development Co., Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
US20220386594A1
(en)
|
2019-11-11 |
2022-12-08 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
AU2019474716A1
(en)
|
2019-11-19 |
2022-07-07 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
Method of treating alzheimer’s disease
|
CN114787181A
(en)
|
2019-11-21 |
2022-07-22 |
Inserm(法国国家健康医学研究院) |
Novel immunotherapy targeting PD-1 with anti-PD-1/IL-15 immunocytokines
|
CN112898414B
(en)
|
2019-12-04 |
2024-05-10 |
珠海泰诺麦博制药股份有限公司 |
Anti-human cytomegalovirus antibodies and uses thereof
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
Systems and methods for identifying cells that have undergone genome editing
|
EP4077731A1
(en)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnosis of frontotemporal dementia
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods of treating atopic dermatitis
|
WO2021137231A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
WO2021137230A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and methods of treating diseases using same
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multispecific antibodies for use in treating diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
EP4096647A1
(en)
|
2020-01-30 |
2022-12-07 |
Yeda Research and Development Co. Ltd |
Treating acute liver disease with tlr-mik inhibitors
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Articles of manufacture comprising anti pd-l1 antibodies and their use in therapy
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Methods of treating cancer
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
CA3170374A1
(en)
|
2020-02-09 |
2021-08-12 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
Method for analyzing cell clusters
|
EP4110823A1
(en)
|
2020-02-26 |
2023-01-04 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
WO2021178637A1
(en)
|
2020-03-05 |
2021-09-10 |
Iowa State University Research Foundation, Inc. |
IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2
|
WO2021186431A1
(en)
|
2020-03-16 |
2021-09-23 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with a mutant p53 protein
|
AU2021245409A1
(en)
|
2020-03-29 |
2022-11-24 |
Yeda Research And Development Co. Ltd. |
Variants of beta-glucocerebrosidase for use in treating Gaucher Disease
|
AU2021248783A1
(en)
|
2020-03-31 |
2022-12-01 |
Biomuse Ltd. |
Bacteria for the prevention and treatment of smoke-induced lung damage
|
WO2021205444A1
(en)
|
2020-04-06 |
2021-10-14 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
WO2021205459A1
(en)
|
2020-04-07 |
2021-10-14 |
Ramot At Tel-Aviv University Ltd. |
Cannabidiol-containing compositions and uses thereof
|
CA3177360A1
(en)
|
2020-04-13 |
2021-10-21 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
WO2021228836A1
(en)
|
2020-05-13 |
2021-11-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Recombinant proteins with ox40 activating properties
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Indexing spatial information for a single-cell downstream applications
|
US20230293530A1
(en)
|
2020-06-24 |
2023-09-21 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
CN116390943A
(en)
|
2020-06-24 |
2023-07-04 |
维尔生物科技有限公司 |
Engineered hepatitis b virus neutralizing antibodies and uses thereof
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
Mage-a1 specific t cell receptor and uses thereof
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
EP4199703A1
(en)
|
2020-08-18 |
2023-06-28 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Method for modulating weight
|
IL301503A
(en)
|
2020-09-23 |
2023-05-01 |
Yeda res & development co ltd |
Methods and compositions for treating coronaviral infections
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
Method of diagnosing breast cancer
|
IL301914A
(en)
|
2020-10-05 |
2023-06-01 |
Protalix Ltd |
Dicer-like knock-out plant cells
|
JP2023545740A
(en)
|
2020-10-07 |
2023-10-31 |
プロタリクス リミテッド |
Long-term active DNase
|
WO2022079719A1
(en)
|
2020-10-15 |
2022-04-21 |
Yeda Research And Development Co. Ltd. |
Method of treating myeloid malignancies
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for rna editing and methods of using same
|
AU2021374966A1
(en)
|
2020-11-09 |
2023-06-15 |
1E Therapeutics, Ltd. |
Catalytic sequence based methods of treating or preventing bacterial infections
|
WO2022115498A1
(en)
|
2020-11-26 |
2022-06-02 |
Ukko Inc. |
Modified high molecular weight glutenin subunit and uses thereof
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling ubiquitination of mlkl for treatment of disease
|
AU2021416356A1
(en)
|
2020-12-28 |
2023-08-10 |
1E Therapeutics, Ltd. |
P21 mrna targeting dnazymes
|
AU2021411103A1
(en)
|
2020-12-28 |
2023-07-13 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
AU2022206415A1
(en)
|
2021-01-10 |
2023-08-17 |
Supermeat The Essence Of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
WO2022153286A1
(en)
|
2021-01-14 |
2022-07-21 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and combinations of same for the treatment or prevention of coronavirus infection
|
EP4284428A1
(en)
|
2021-01-26 |
2023-12-06 |
VIR Biotechnology, Inc. |
Compositions and methods for treating hepatitis b virus infection
|
EP4294429A1
(en)
|
2021-02-18 |
2023-12-27 |
Yeda Research and Development Co. Ltd |
Genetically modified bacteria for generating vaccines
|
JP2024506955A
(en)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
How to make a vaccine
|
CN118019759A
(en)
|
2021-03-10 |
2024-05-10 |
莫比伦有限公司 |
Anti-TDP-43 antibodies and methods of use thereof
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for ex-utero mouse embryonic development
|
CA3213424A1
(en)
|
2021-03-30 |
2022-10-06 |
Lior Moshe ZELCBUCH |
Pseudomonas bacteriophage and uses thereof
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
A combined use of ketamine and retigabine (ezogabine) for the treatment of psychiatric disorders
|
EP4337764A1
(en)
|
2021-05-12 |
2024-03-20 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Anti-microbial peptide (amp) signatures for diagnostics, stratification, and treatment of microbiome-associated disease
|
CA3219233A1
(en)
|
2021-06-06 |
2022-12-15 |
Ravid STRAUSSMAN |
Combined treatment for cancer
|
CN117836402A
(en)
|
2021-06-13 |
2024-04-05 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
Method for reprogramming human cells
|
CR20240020A
(en)
|
2021-06-16 |
2024-02-28 |
Seedx Tech Inc |
Methods of sorting matthiola seeds
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
JP2024524924A
(en)
|
2021-07-02 |
2024-07-09 |
トロピック バイオサイエンシーズ ユーケー リミテッド |
Delaying or preventing browning in banana fruit
|
AU2022313138A1
(en)
|
2021-07-18 |
2024-02-29 |
Gamida-Cell Ltd. |
Therapeutic nk cell populations
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
EP4380966A2
(en)
|
2021-08-03 |
2024-06-12 |
Genicity Limited |
Engineered tcr complex and methods of using same
|
IL310716A
(en)
|
2021-08-10 |
2024-04-01 |
Gamida Cell Ltd |
Engineered nk cells, methods of their production and uses thereof
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in treating diseases
|
WO2023105526A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|
WO2023242155A1
(en)
|
2022-06-14 |
2023-12-21 |
Janssen Vaccines & Prevention B.V. |
Compositions and methods for the diagnosis of hiv infection
|